USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
25-May-2005
North America
Market Research
F337-01-00-00-00
HC01446-NA-MR_05925
The U.S. Therapeutic Monoclonal Antibodies Markets is a evolving market undergoing many changes. This research service includes in depth analysis of the total market as well as the various therapeutic classes for which monoclonal antibodies are available. This analysis includes revenue forecasts, product/pipeline analysis, and strategic perspectives of the market. A number of strategic recommendations to be successful are provided in the research service.
Executive Summary
- Executive Summary
Objectives and Scope
- Objectives
- Scope
Monoclonal Antibodies Market Overview
- Introduction
- Structure of Antibodies
- Typical Problems with Murine mAbs
- The Role of Hybridoma Clone
- Medical Utility of mAbs
- Market Overview
Evolution and Technology Trends
- Introduction
- Early Murine mAbs
- Chimeric mAbs
- Humanized mAbs
- Fully Human mAbs
- Phage Display of Human mAbs
- Monoclonal Antibodies as Carriers
- Naked Monoclonal Antibodies
- Conjugated Monoclonal Antibodies
Future of Monoclonal Antibodies
- The Foundation for Optimistic Future
- Return on Investment and Future
Challenges Affecting the US Therapeutic Monoclonal Antibodies Market
Overview of the mAbs Pipeline
Market Dynamics
Market Forecasts
Frost and Sullivan Awards
- Introduction
- Market Engineering Measurement
- Market Drivers
- Market Restraints
Competitive Structure
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Strategic Recommendations
Oncology Databases
Autoimmune and Inflammatory Disorders Databases
Organ Transplant Databases
Cardiovascular Databases
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
25 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...
23 Sep 2026 | Global | Technology Research
Programmable Epigenome Editing for Disease Reversal
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F337-01-00-00-00 |
| Is Prebook | No |
U.S. Therapeutic Monoclonal Antibodies Markets
$2,450.00
Special Price $1,837.50 save 25 %